DENTSPLY SIRONA Inc.

NASDAQ:XRAY

Medical - Instruments & Supplies

Healthcare
$8.52 +1.84%

+$0.19 today

Market cap
$1.70B
Beta
0.91
P/E (TTM)
-3.3
EPS (TTM)
-$3.14
Dividend yield
6.27%
52W Low $9.41High $17.09

Volume 5.40M

Average 4.70M

XRAY Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

DENTSPLY SIRONA Inc.NASDAQ: XRAY

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit declines year over year

Q1 FY2026 gross profit of $427M fell 8.4% year over year, behind the -6.1% change in trailing-twelve-month gross profit. Sequentially, it fell 3.6% from the prior quarter. Over 3 fiscal years it compounded at -4.7% a year.

Context

  • Gross profit amounted to 50.0% of revenue in FY2025, down 1.6 pp from a year earlier.
  • Gross profit increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -8.4% toward the trailing-twelve-month pace of -6.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$427M-3.6% QoQ
Last fiscal yearDec 2025
$1.84B-6.0% YoY
LTMMar 2026
$1.8B-6.1% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-8.4%——
1 year-6.0%——
3-year CAGR-4.7%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
1.84B USD
Year-over-year change
-6.0%
4-year CAGR
-5.9%

Gross Profit vs competitors

How XRAY compares with its peers on the latest reported figures

  • XRAY's LTM Mar 2026 gross profit of $1.8B is the 3rd highest of the 4 companies compared; the peer median is $2.75B.
  • Its year-over-year change of -6.1% is the lowest of 4, against a peer median of +10.0%.
  • Gross profit amounts to 48.9% of revenue for XRAY, versus a peer median of 56.0%.
XRAY Competitors Peer median
Gross Profit for XRAY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HSICHenry Schein, Inc.LTM Jun 2026$4.12B +10.0%+1.7%30.3%
ALGNAlign Technology, Inc.LTM Jun 2026$2.75B -0.5%+1.5%66.5%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$1.8B -6.1%-4.7%48.9%
NVSTEnvista Holdings CorpLTM Oct 2026$1.61B +10.7%+0.2%56.0%
Peer median (excluding XRAY) $2.75B+10.0%+1.5%56.0%

Competitors are the stored peer set for XRAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.23B3.92B3.97B3.79B3.68B
Cost of Revenue1.88B1.8B1.88B1.84B1.84B
Gross Profit2.35B2.13B2.09B1.96B1.84B
Gross Margin55.5%54.2%52.6%51.6%50.0%
Research & Development171M174M184M165M150M
Selling, General & Admin1.55B1.59B1.61B1.61B1.44B
Operating Expenses1.74B3.06B2.17B2.84B1.59B
Depreciation & Amortization346M328M343M349M352M
EBITDA952M(662M)249M(518M)(46M)
EBITDA Margin22.5%-16.9%6.3%-13.7%-1.3%
Operating Income608M(937M)(85M)(879M)252M
Operating Margin14.4%-23.9%-2.1%-23.2%6.8%
Interest Income00000
Interest Expense61M65M81M69M88M
Other Income / Expenses(63M)(118M)(90M)(57M)(738M)
Income Before Tax545M(1.06B)(175M)(936M)(486M)
Pre-Tax Margin12.9%-26.9%-4.4%-24.7%-13.2%
Income Tax Expense134M(105M)(43M)(26M)112M
Net Income411M(950M)(132M)(910M)(598M)
Net Margin9.7%-24.2%-3.3%-24.0%-16.3%
EPS (Basic)1.88(4.41)(0.62)(4.48)(3.00)
EPS (Diluted)1.87(4.41)(0.62)(4.48)(3.00)
Weighted Avg Shares218.4M215.5M212M203.2M199.4M
Weighted Avg Shares (Diluted)220.2M215.5M212M203.2M199.4M

DENTSPLY SIRONA Inc.

NASDAQ:XRAY

Intrinsic Alpha fair value

Locked

Current Price

$8.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.